Gujarat Fluorochemicals Q1 FY27: Strong Chemical Growth, ₹3,100 Crore FY27 Capex and Battery Materials Set for Scale-Up

Gujarat Fluorochemicals Limited (GFL) has started FY27 on a strong note, with healthy growth across its core chemical businesses and improving profitability. In its Q1 FY27 earnings call held on August 12, 2026, management highlighted strong demand for fluoropolymers and refrigerants, improving product mix, better operating leverage and continued progress in advanced battery materials. The company believes FY27 could be an important year as earlier investments begin contributing meaningfully, while new capacity additions are expected to support the next phase of growth.

Q1 FY27 Results

GFL reported 24% year-on-year growth in consolidated revenue to ₹1,588 crore, while consolidated EBITDA increased 24% to ₹428 crore and PAT rose 19% to ₹219 crore. The Chemical segment was particularly strong, with revenue increasing 23% YoY to ₹1,574 crore, EBITDA rising 29% to ₹458 crore and segment PAT growing 33% to ₹261 crore. On a sequential basis, Chemical segment revenue increased 16%, EBITDA jumped 30% and PAT surged 56%. Consolidated EBITDA margin improved sharply from 22% in Q4 FY26 to 27% in Q1 FY27, while PAT margin expanded from 7% to 14%. ROCE improved to 16.6% from 14%, ROE increased to 15.18% from 12.17%, and working-capital days declined significantly from 192 days to 149 days.

Fluoropolymers and Fluorochemicals Drive Growth

The fluoropolymer business recorded 15% YoY and 8% QoQ revenue growth, supported by higher volumes of new-generation fluoropolymers and a shift towards higher-value products. Management said growth is increasingly coming from applications in semiconductors, data centres, automotive, green hydrogen and other advanced industrial sectors. The fluorochemical business delivered an even stronger performance, with revenue jumping 52% YoY and 44% QoQ, primarily driven by R32 refrigerant sales. Existing R32 capacity is already operating at almost full utilization, while the company expects additional capacity to help address growing global demand.

Capex and Expansion Plans

GFL is maintaining its previously announced FY27 capex plan of around ₹2,300 crore for the EV/battery materials business and approximately ₹800 crore for the chemical business, taking the FY27 planned spending to roughly ₹3,100 crore. The company has an overall capex plan of around ₹6,000 crore over the broader expansion cycle. Management expects capital work in progress to reach around ₹1,200 crore by the end of the current year as projects are progressively commissioned and stabilized. In addition, GFL is investing in new fluoropolymer capacity and continuous debottlenecking to cater to demand from high-growth applications.

Oman Battery Project Put on Hold, Capacity to Shift to India

One of the major developments discussed during the earnings call was the decision to put the Oman battery-materials project on hold. Management said geopolitical and project-delay considerations led to the decision to shift the planned capacities to India. The company intends to utilize its existing Dahej B/Jolva site, where land, infrastructure and approvals are already available, while another Dahej-area site is also being added for future expansion. Management indicated that the Indian battery ecosystem has become more attractive because of rising domestic demand, particularly from battery energy storage systems (BESS), as well as supportive policy developments.

Future Plan: Battery Materials Could Become a Major Growth Driver

GFL expects its advanced battery materials business to move into a much stronger growth phase after completing customer qualification and commercialization. LiPF6 is already approaching the growth phase, while PVDF qualification is nearing completion and LFP and cathode active materials are progressing through their respective stages. Management expects battery-material revenue to reach a three-digit quarterly figure by Q4 FY27, with a significant scale-up expected during FY28. The company believes the ramp-up of newer investments should be faster because customer qualification and initial stabilization processes will largely have been completed.

R32 Expansion and Refrigerant Opportunity

R32 remains one of the key near-term growth opportunities for GFL. The company is expanding its R32 capacity, with the new capacity expected to be commissioned in Q2 FY27, while management expects the total R32 capacity to be fully utilized as additional capacity becomes available. GFL is targeting both domestic and international markets, with sales comprising a combination of long-term contracts and spot/contract-to-contract business. The company also has the advantage of producing both R32 and R125, allowing it to participate not only in standalone R32 sales but also in R410 blends. An R134A project is also being implemented as a brownfield expansion and is expected to be commissioned during FY27.

Fluoropolymer Growth Could Remain Strong

Management reiterated its expectation of around 17%-20% annual growth in fluoropolymers, supported by volume growth and increasing contribution from high-value grades. Rather than relying primarily on commodity pricing, GFL is focusing on moving up the value chain. Products such as PVDF are benefiting from battery applications, while PFA and FKM are seeing demand from semiconductor applications. The company is also witnessing opportunities in data centres and green hydrogen, with customer approvals progressing and commercial volumes expected to increase as qualifications are completed.

Management Commentary

Management remained confident about GFL’s growth outlook despite a challenging global environment characterized by supply-chain disruptions, commodity-price volatility and geopolitical uncertainty. The company believes its integrated manufacturing capabilities, established customer relationships and diversified exposure to fluorochemicals, fluoropolymers and battery materials provide a strong foundation for long-term growth. Management also emphasized disciplined capital allocation, improving returns and working-capital efficiency. According to the company, earlier capex investments have now started contributing meaningfully to financial performance, while advanced battery materials are expected to become an increasingly important contributor over the next few years.

Important Takeaways for Investors

One of the biggest takeaways from the Q1 FY27 call is that GFL is entering a potentially important transition phase. Its established fluorochemical and fluoropolymer businesses are already generating strong cash flows, while R32 capacity expansion can provide a near-term growth catalyst. At the same time, the battery-materials business is moving from qualification and initial commercialization towards a larger-scale revenue phase. The shift of the Oman project to India could also accelerate execution, although the large capex program means funding, execution and return on capital will remain important factors to monitor. Additionally, potential demand opportunities following capacity exits by global players such as AGC could provide another opportunity for GFL’s high-value fluoropolymer portfolio.

Outlook

Gujarat Fluorochemicals enters the rest of FY27 with multiple growth levers, including R32 expansion, R134A commercialization, higher-value fluoropolymers, new-age fluoropolymer capacity and the gradual scaling of battery materials. Management expects fluoropolymers to grow at 17%-20% annually and sees significant battery-material traction emerging towards the end of FY27 and more strongly in FY28. If the company executes its planned capex successfully and customer qualifications convert into commercial volumes, the combination of core chemical growth and emerging battery-material opportunities could become a key driver of GFL’s long-term earnings growth.

Disclaimer: This article is for informational and educational purposes only and should not be considered investment advice, a recommendation to buy or sell any stock, or a guarantee of future returns. Investors should conduct their own research and consult a SEBI-registered investment adviser before making investment decisions. The information above is based on the company’s Q1 FY27 earnings conference call and management commentary and may be subject to change.